[1]
2022. Radiolabeled Peptide as Diagnostic, Therapeutic, and Theranostic agents for Prostate Cancer: Systematic Literature Review. Pharmaceutical Reports. 1, 1 (Mar 2022). DOI:https://doi.org/10.33096/pharmrep.v1i1.174.